Daxor (DXR) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DXR Daxor Corp DXR
47 GF Score
Price $10.20
GF Value $37.53
Valuation Possible Value Trap
! 1 Warning Sign
View Full Analysis

What is Daxor Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.


DXR vs POCI, NEPH, MLSS: Short Percentage of Float Comparison

For the Medical Instruments & Supplies subindustry, Daxor's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daxor Short Percentage of Float vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Daxor's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Daxor's Short Percentage of Float falls into.


DXR
47GF Score
Daxor Corp DXR
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Daxor (DXR) Overvalued in 2026?

Based on GuruFocus' analysis, Daxor stock appears to be undervalued. The current stock price of $10.20 is trading 72.8% below its estimated GF Value™ of $37.53. GuruFocus considers Daxor to be Possible Value Trap.

Key valuation signals for DXR:

  • Short Percentage of Float:
  • GF Value™: $37.53 vs. price of $10.20 (72.8% below fair value)
  • GF Score™: 47/100 with 1 warning sign

No single metric tells the full story. See the DXR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Daxor Business Description

Other Exchanges DX5:Germany
Address 107 Meco Lane, Oak Ridge, TN, USA, 37830
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.
47GF Score

Get the complete analysis for DXR

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.20
Price
$37.53
GF Value